НовостиBenzingaWedbush Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $17 Wedbush Initiates Coverage On Eupraxia Pharmaceuticals with Outperform Rating, Announces Price Target of $17 Benzinga 2026.09.24 12:38 (GMT+0) Открыть на Benzinga Другие новости